clinical trial · NCT07052253
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
Akeso·phase2·recruiting·n = 100
Hepatocellular Carcinoma (HCC)TT-00420 (tinengotinib)AK104AK112
brief summary
An Open-label, Multicenter, Phase II Clinical Study of AK104/AK112 in Combination with TT-00420 Tablet in Patients with Advanced Hepatocellular Carcinoma(HCC).
started
Jul 18, 2025
primary completion
May 10, 2027
completion
Dec 31, 2027
last updated
Mar 16, 2026
official title
An Open-label, Multicenter, Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet in Patients With Advanced Hepatocellular Carcinoma.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol